Imperial, Robin
Ahmed, Zaheer
Toor, Omer M.
Erdoğan, Cihat
Khaliq, Ateeq
Case, Paul
Case, James
Kennedy, Kevin
Cummings, Lee S.
Melton, Niklas
Raza, Shahzad
Diri, Banu
Mohammad, Ramzi
El-Rayes, Bassel
Pluard, Timothy
Hussain, Arif
Subramanian, Janakiraman
Masood, Ashiq
Funding for this research was provided by:
U.S. Department of Veterans Affairs (Merit Review Award, I01 BX000545)
Article History
Received: 28 August 2018
Accepted: 30 November 2018
First Online: 21 December 2018
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: Ashiq Masood Advisory board and speaker Bureau Bristol-Myers Squibb and Boehringer Ingelheim, Honorarium Biocept. Janakiraman Subramanian Advisory board - Astra Zeneca, Pfizer, Boehringer Ingelheim, Alexion, Paradigm, Bristol-Myers Squibb Speakers Bureau - Astra Zeneca, Boehringer Ingelheim, Lilly Research Support - Biocept and Paradigm. Arif Hussain Advisory board – Novartis, Bayer, Astra Zeneca, Consultant – Bristol-Myers-Squibb. All other authors declare that they have no competing interest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.